¿Cuál es el sitio web?

Bionatura Journal

BioNatura Journal is a peer-reviewed, open-access journal focused on biotechnology, life sciences, and health.

It promotes Ibero-American research with international visibility, academic rigor, bilingual publication, and fast editorial response.

07/10/2026

How can maternal microbiota and birth mode influence the development of a newborn's gut microbiome? 👶🦠
A new Open Access Review Article in BioNatura Journal examines how maternal microbial communities and early-life exposures shape neonatal gut colonization and immune development.
The review highlights:
✅ Maternal microbiota are an important source of early microbial exposure
✅ Vaginal birth is associated with greater exposure to maternal microorganisms
✅ Cesarean delivery and antibiotic exposure may alter early colonization patterns
✅ Delayed establishment of beneficial bacteria such as Bifidobacterium may affect immune signaling
✅ Multi-omics and bioinformatics are helping researchers understand complex mother–infant microbial interactions
✅ Machine learning has potential for risk prediction, but larger and externally validated studies are still required
The article connects microbiology, immunology and computational science to examine how the earliest microbial events in life may influence later health.
Read the full Open Access review:
🔗 https://bionaturajournal.com/repositorio/index.php/bionatura/article/view/293
📄 DOI: 10.70099/BJ/2026.03.03.10
Authors: Sania Khurshid & Yusuf Munir Aliyu
HASHTAGS:

06/10/2026

Can HPV genotyping be made more affordable for laboratories with limited resources? 🧬🔬
A new Open Access study published in BioNatura Journal presents an in-house PCR-RFLP workflow developed in Ecuador.
The researchers report:
✅ 12 cervical samples processed
✅ 2 HPV-positive samples
✅ An approximately 450-bp HPV L1 region amplified by PCR
✅ Four restriction enzymes used for genotype-pattern analysis
✅ Potential discrimination of up to 49 HPV types
✅ Preliminary direct reagent cost of approximately US$17 per sample
The strategy uses conventional molecular-biology techniques and illustrates the potential of frugal innovation in molecular diagnostics.
However, this is a proof of concept, not a clinically validated diagnostic assay. Larger studies, independent genotype confirmation and full analytical validation are still required.
Read the full Open Access article:
🔗 https://bionaturajournal.com/repositorio/index.php/bionatura/article/view/335
📄 DOI: 10.70099/BJ/2026.03.03.12
HASHTAGS:

05/10/2026

How efficiently can recombinant SARS-CoV-2 RBD-His bind to an IMAC purification matrix? 🧪
A new Open Access study in BioNatura Journal investigated adsorption of recombinant RBD-His onto Ni²⁺-Chelating Sepharose Fast Flow.
The researchers found:
✅ Stable adsorption equilibrium after about 240 minutes
✅ Best kinetic fit with a pseudo-second-order model
✅ Evidence that external-film resistance contributes during the initial stage
✅ A multistep adsorption process rather than a single controlling mechanism
✅ Maximum Langmuir capacities of 58.62 mg/mL for monomeric RBD-His and 53.00 mg/mL for the dimeric form
These results provide useful quantitative information for improving protein purification, column modeling and scale-up.
Read the full Open Access article:
🔗 https://bionaturajournal.com/repositorio/index.php/bionatura/article/view/334
📄 DOI: 10.70099/BJ/2026.03.03.15
HASHTAGS:

02/10/2026

Can reported chemical treatment status be associated with changes in the biological properties of edible mushrooms? 🍄🔬
A new exploratory study in BioNatura Journal compared Pleurotus ostreatus and Agaricus bisporus samples classified by a supplier as treated or untreated.
The researchers observed:
✅ 30 positive phytochemical reactions in untreated samples
✅ 21 positive + 2 trace-positive reactions in supplier-reported treated samples
✅ Larger mean E. coli inhibition zones in untreated aqueous extracts
✅ Operational minimum inhibitory volume of 50 µL untreated vs 100 µL reported-treated
These results are interesting, but they need to be interpreted carefully.
⚠️ Formaldehyde exposure was not analytically verified, and the study used technical rather than independent biological replicates. The authors therefore describe the findings as exploratory and hypothesis-generating, not proof of a causal effect.
Read the full Open Access article:
🔗 https://bionaturajournal.com/repositorio/index.php/bionatura/article/view/329
📄 DOI: 10.70099/BJ/2026.03.03.14
HASHTAGS:

01/10/2026

Can two accessible biopolymers become an effective platform for drug delivery? 🧪💊
A new study published in BioNatura Journal investigated microparticles made from chitosan and alginate using ionotropic gelation.
The results are promising:
✅ Core–shell particles achieved 35–55% higher encapsulation capacity
✅ Stable interactions between chitosan and alginate were confirmed by ATR-FTIR
✅ Cell viability remained above 90% at working dilutions
✅ Hemolysis remained below 2%
✅ The preparation procedures were simple and reproducible
The study supports further development of chitosan–alginate microparticles as an accessible platform for biomedical and drug-delivery research.
Read the full Open Access article:
🔗 https://bionaturajournal.com/repositorio/index.php/bionatura/article/view/325
📄 DOI: 10.70099/BJ/2026.03.03.6
HASHTAGS:

30/09/2026

Can artificial intelligence simplify cardiovascular risk assessment? ❤️🧠
A new study published in BioNatura Journal developed a simplified prognostic scale for hypertensive heart disease progression using an artificial neural network.
What did the researchers find?
✅ 3,082 patients were studied
✅ The model was reduced from 14 factors to 10 factors
✅ The strongest predictors were uncontrolled hypertension, stage 2 hypertension, and chronic kidney disease
✅ Internal validation showed high predictive performance (AUC 0.892–0.988)
✅ The tool may help improve risk stratification in clinical practice
✅ However, external validation is still required before clinical use
Read the full Open Access article:
🔗 https://bionaturajournal.com/repositorio/index.php/bionatura/article/view/309
📄 DOI: 10.70099/BJ/2026.03.03.13
HASHTAGS:

28/09/2026

A new study in BioNatura Journal analyzed the length–weight relationship and condition factor of black tiger shrimp (Penaeus monodon) reared in earthen ponds during the monsoon season in Gujarat, India.
What did the researchers find?
✅ 1,000 shrimp were analyzed
✅ Shrimp showed negative allometric growth in both ponds
✅ Length increased proportionally more than weight
✅ Mean condition factor values were 0.725 and 0.734
✅ The results can help improve feeding, stocking density, and overall farm management
This is a useful contribution for aquaculture professionals interested in sustainable shrimp production and better decision-making under seasonal pond conditions.
Read the full Open Access article here:
🔗 https://bionaturajournal.com/repositorio/index.php/bionatura/article/view/275
📄 DOI: 10.70099/BJ/2026.03.03.11
HASHTAGS:

27/09/2026

Can beneficial microbes help improve soil fertility and carbon retention? 🌱
A new study published in BioNatura Journal used FTIR spectroscopy to investigate how microbial inoculation changes soil organic matter in semi-arid Iraqi agricultural soils.
The researchers found that:
✅ Microbial treatments changed signals associated with soil organic matter
✅ Rhizobium + mycorrhiza produced the strongest response
✅ The surface soil showed the clearest changes
✅ Deeper layers retained signals associated with more stable organic structures
✅ These interactions may be relevant for soil fertility and longer-term carbon retention
Read the full Open Access article:
🔗 https://bionaturajournal.com/repositorio/index.php/bionatura/article/view/253
📄 DOI: 10.70099/BJ/2026.03.03.4

24/09/2026

A new study explores the impact of Point-of-Care Ultrasound (POCUS) in a Latin American ICU and shows its value for faster decision-making, high diagnostic agreement, and improved patient management in critical care.

Key highlights:
• 74% POCUS-guided interventions
• 92% diagnostic agreement
• 98% procedure success
• 1.5-day reduction in ICU stay with early POCUS integration

Read the full article here:
https://bionaturajournal.com/repositorio/index.php/bionatura/article/view/230

19/09/2026

CALL FOR PAPERS – December 2026 Issue

BioNatura Journal is now receiving manuscripts for the final issue of 2026, to be published in December.

We welcome submissions in biotechnology, biomedical sciences, life sciences, and related fields.

✅ Diamond Open Access
✅ No publication fees — APC €0
✅ Peer-reviewed
✅ International scientific journal

📄 Submit your manuscript here:
https://bionaturajournal.com/submit-a-manuscript.html

Please share this call with colleagues, research groups, universities, and scientific networks.

BioNatura Journal
ISSN 3020-7886
Science today for a healthier tomorrow.

Dirección

Madrid
28029

Página web

https://bionaturajournal.com/index.html

Notificaciones

Sea el primero en enterarse: le enviaremos un correo electrónico cuando Bionatura Journal publique novedades y promociones. Su dirección de correo electrónico no se utilizará para ningún otro fin y puede darse de baja en cualquier momento.

¿Quieres que tu empresa aparezca en primer lugar en la categoría compañía de medios en Madrid?